mcdonagh47
Well-Known Member
- Messages
- 79
We can all compare notes in thirty years
.
.Hopefully.
During 215 725 person-years of follow-up, 2866 patients developed diabetic retinopathy, 1406 developed diabetic neuropathy, 1248 developed diabetic nephropathy, and 2392 developed gangrene of the foot. Compared with non-statin users, statin users had a lower cumulative incidence of diabetic retinopathy (hazard ratio 0·60, 95% CI 0·54—0·66; p<0·0001), diabetic neuropathy (0·66, 0·57—0·75; p<0·0001), and gangrene of the foot (0·88, 0·80—0·97; p=0·010), but not diabetic nephropathy (0·97, 0·85—1·10; p=0·62). These results were similar after adjusting for the competing risk of death, after matching for a propensity score, after adjusting for visits to a family doctor, and by stratification on covariates. The corresponding multivariable adjusted hazard ratio for risk of diabetes in the total population was 1·17 (95% CI 1·14—1·21; p<0·0001).
Conventionally, probabilities lower than .05 are considered significant and researchers provide a 95% confidence interval for the hazard ratio, e.g. derived from the standard deviation of the Cox-model regression coefficient, i.e..[7][8] Statistically significant hazard ratios cannot include unity (one) in their confidence intervals.[5]
So the statins made more people diabetic, but with less of the diabetics getting complications. If I was non-diabetic I would not be reaching for the statins!it was a snapshot of 60,000 people after av. 2.7 years with a statistical reduction, they aren't claiming the holy grail
AFAIK neutral HR=1 but I'm happy to be corrected
statin use
retinopathy HR=0.6 [decrease of risk]
neuropathy HR=0.66
gangrene of the foot HR=0.88
diabetic nephropathy HR=0.97
diabetes HR=1·17 [increase of risk]
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?